Literature DB >> 23871702

Trends in antihypertensive drug prescription patterns among ambulatory stroke patients in the United States, 2000-2009.

Bruce Ovbiagele1, Karin Ernstrom, Daniela Markovic, Rema Raman.   

Abstract

BACKGROUND: Although the ambulatory setting is recognized as the best arena for optimizing antihypertensive drug treatment after a stroke, little is known about recent office-based antihypertensive drug treatment patterns in the United States. We assessed national trends in antihypertensive treatment for stroke patients in office-based medical practice.
METHODS: Data from the 2000-2009 National Ambulatory Medical Care Surveys were analyzed comprising outpatient visits to physicians in office-based practice by patients aged 40 years or older with a diagnosis of stroke (weighted estimate=46,317,269). The main outcome measure was visits with a prescription of antihypertensive medication(s).
RESULTS: The proportion of total visits that included a prescription of antihypertensive medication was 35.6% in 2000-2002, 29.5% in 2003-2005, and 49.3% in 2006-2009 (P=.002); 50.9% were primary care physician (PCP) visits versus 26.2% neurologist visits (P<.0001). Age-adjusted logistic regression analyses confirmed a higher prescription rate in 2006-2009 versus 2000-2002 (1.81; 95% confidence interval [CI], 1.10-2.96) and PCP versus neurologists (2.82; 95% CI, 1.86-4.27). Use of 2 or more agent classes was 31.6% in 2000-2002, 44.2% in 2003-2005, and 56.7% in 2006-2009 (P=.014). Age-adjusted logistic regression analyses confirmed a higher prescription rate of 2 or more agent classes in 2006-2009 versus 2000-2002 (2.96; 95% CI, 1.40-6.24). There were no significant differences in agent class type or number between neurologists versus PCPs.
CONCLUSIONS: Over the last decade, there was a significant rise in the use of antihypertensive drugs and combination of agent classes for patients aged 40 years or older seen in an ambulatory setting with a diagnosis of stroke. PCPs were more likely than neurologists to prescribe these agents.
Copyright © 2013 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; antihypertensive; blood pressure; health services; hypertension; target goals

Mesh:

Substances:

Year:  2013        PMID: 23871702      PMCID: PMC4084703          DOI: 10.1016/j.jstrokecerebrovasdis.2013.06.022

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  24 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke.

Authors:  Bruce Ovbiagele; Lee H Schwamm; Eric E Smith; Adrian F Hernandez; DaiWai M Olson; Wenqin Pan; Gregg C Fonarow; Jeffrey L Saver
Journal:  Stroke       Date:  2010-05-27       Impact factor: 7.914

3.  Office-based medical practices: methods and estimates from the national ambulatory medical care survey.

Authors:  Esther Hing; Catharine W Burt
Journal:  Adv Data       Date:  2007-03-12

4.  Making patient-level estimates from medical encounter records using a multiplicity estimator.

Authors:  Catharine W Burt; Esther Hing
Journal:  Stat Med       Date:  2007-04-15       Impact factor: 2.373

5.  30-day survival and rehospitalization for stroke patients according to physician specialty.

Authors:  Maureen A Smith; Jinn-Ing Liou; Jennifer R Frytak; Michael D Finch
Journal:  Cerebrovasc Dis       Date:  2006-03-27       Impact factor: 2.762

6.  Population trends and disparities in outpatient utilization of neurologists for ischemic stroke.

Authors:  Sudeep Karve; Rajesh Balkrishnan; Eric Seiber; Milap Nahata; Deborah A Levine
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-22       Impact factor: 2.136

7.  Characteristics of office-based physicians and their practices: United States, 2003-04.

Authors:  Esther Hing; Catharine W Burt
Journal:  Vital Health Stat 13       Date:  2007-01

8.  Validating administrative data in stroke research.

Authors:  David L Tirschwell; W T Longstreth
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

9.  Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study.

Authors:  Kate Hardie; Graeme J Hankey; Konrad Jamrozik; Robyn J Broadhurst; Craig Anderson
Journal:  Stroke       Date:  2004-02-05       Impact factor: 7.914

10.  Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data.

Authors:  Christianne L Roumie; Edward Mitchel; Patricia S Gideon; Cristina Varas-Lorenzo; Jordi Castellsague; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-01       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.